UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036873
Receipt number R000042015
Scientific Title Analysis of clinical features and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis
Date of disclosure of the study information 2019/06/01
Last modified on 2021/11/30 23:42:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of clinical features and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis

Acronym

Analysis of clinical features and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis

Scientific Title

Analysis of clinical features and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis

Scientific Title:Acronym

Analysis of clinical features and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis

Region

Japan


Condition

Condition

anti-neutrophil cytoplasmic antibody associated vasculitis

Classification by specialty

Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

analysis of clinical features and prognosis

Basic objectives2

Others

Basic objectives -Others

To study organ involvement associated with vasculitis, outcomes of relapses, occurrences of adverse events, discontinuing of immunosuppressants, and survival rate.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To study outcomes of relapses, occurrences of adverse events, discontinuing of immunosuppressants, and survival rate, for five years.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with vasculitis, whose ANCA is positive, attending Clinical Immunology and Rheumatology, Jichi Medical University Hospital.

Key exclusion criteria

none

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Takamasa
Middle name
Last name Murosaki

Organization

Jichi Medical University Hospital

Division name

Clinical Immunology and Rheumatology

Zip code

3290498

Address

3311-1, Yakushiji, Shimotsuke-city, Tochigi prefecture

TEL

0285587358

Email

r0752tm@jichi.ac.jp


Public contact

Name of contact person

1st name Takamasa
Middle name
Last name Murosaki

Organization

Jichi Medical University Hospital

Division name

Clinical Immunology and Rheumatology

Zip code

3290498

Address

3311-1, Yakushiji, Shimotsuke-city, Tochigi prefecture

TEL

0285587358

Homepage URL


Email

r0752tm@jichi.ac.jp


Sponsor or person

Institute

Jichimedical University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

JIchi Medical University

Address

3311-1, Yakushiji, Shimotsuke-city, Tochigi prefecture

Tel

0285588933

Email

rinri@jichi.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 06 Month 01 Day


Related information

URL releasing protocol

https://pubmed.ncbi.nlm.nih.gov/32996696/

Publication of results

Unpublished


Result

URL related to results and publications

https://pubmed.ncbi.nlm.nih.gov/32996696/

Number of participants that the trial has enrolled

162

Results

The multivariable Cox proportional hazards regression analysis showed that age over than 65: HR 1.69, 95 percent CI 1.07 to 2.81, p equal 0.025, performance status of 3 to 4: HR 1.98, 95 percent CI 1.21 to 3.23, p equal 0.008, cumulative dose of prednisolone over than 1,500mg : HR 2.21, 95 percent CI 1.37 to 3.81, p lower than 0.001, and oral cyclophosphamide: HR 1.84, 95 percent CI 1.13 to 3.00, p equal 0.016 were independent risk factors for immunosuppressant discontinuation.

Results date posted

2021 Year 11 Month 30 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

162 patients who diagnosed with ANCA associate vasculitis from 2005 to 2016 in our institution

Participant flow

50 patients who were treated with immunosuppressant for initial remission induction

Adverse events

none (this is retrospective study)

Outcome measures

Discontinuation of immunosuppressant due to adverse event was evaluated.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 05 Month 28 Day

Date of IRB

2019 Year 09 Month 26 Day

Anticipated trial start date

2019 Year 05 Month 28 Day

Last follow-up date

2020 Year 06 Month 09 Day

Date of closure to data entry

2020 Year 06 Month 09 Day

Date trial data considered complete

2020 Year 06 Month 09 Day

Date analysis concluded

2020 Year 06 Month 09 Day


Other

Other related information

We analyze the clinical informations including clinical features, for example relapse, organ involvement, adverse event, discontinuing of immunosuppressant, and survival rate, retrospectively, about patients with ANCA associated vasculitis attending our devision.


Management information

Registered date

2019 Year 05 Month 28 Day

Last modified on

2021 Year 11 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042015


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name